Experience with aromatase inhibitors in the treatment of advanced breast cancer
- 1 April 1993
- journal article
- research article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 19, 37-44
- https://doi.org/10.1016/0305-7372(93)90006-d
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Aminoglutethimide in advanced breast cancer: Clinical results of a French multicenter randomized trial comparing 500 mg and 1 g/dayEuropean Journal of Cancer and Clinical Oncology, 1985
- Aminoglutethimide in the treatment of advanced breast cancerCancer Treatment Reviews, 1984
- Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancerBritish Journal of Cancer, 1983
- Aminoglutethimide for the treatment of advanced postmenopausal breast cancerEuropean Journal of Cancer and Clinical Oncology, 1983
- A Randomized Trial Comparing Surgical Adrenalectomy with Aminoglutethimide plus Hydrocortisone in Women with Advanced Breast CancerNew England Journal of Medicine, 1981
- Cancer of the BreastNew England Journal of Medicine, 1980
- Cancer of the BreastNew England Journal of Medicine, 1980
- Aminoglutethimide Inhibits Extraglandular Estrogen Production in Postmenopausal Women with Breast Carcinoma*Journal of Clinical Endocrinology & Metabolism, 1978
- Preliminary trial of aminoglutethimide in breast cancerCancer, 1973
- Aminoglutethimide (Elipten-Ciba) as an Inhibitor of Adrenal Steroidogenesis: Mechanism of Action and Therapeutic TrialJournal of Clinical Endocrinology & Metabolism, 1967